Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Dr John Nash, Senior Director ADME/PK, BioFocus

November 3, 2009 Research and Development appointment, biofocus, research and development

BioFocus, a leading provider of gene-to-drug candidate discovery services, has appointed Dr John Nash as senior director, ADME/PK.  John has …
Appointment

Phase III success for GSK’s lupus drug

November 3, 2009 Research and Development, Sales and Marketing Benlysta, GSK

 GlaxoSmithKline’s lupus drug Benlysta has been successful in the second of two phase III trials, following earlier performance that exceeded …
News

Whatever happened to yesterday’s ‘magic bullets’?

November 3, 2009 Research and Development Les Rose, biotech

How many of you remember when monoclonal antibodies were called `magic bullets’? Enough time has passed since the term first …
Feature

Fast times at contract research firm PPD

November 3, 2009 Research and Development CRO

Pharmaceutical Product Development (PPD) has unveiled several new initiatives to re-inject some growth momentum into the business as its third-quarter …
News

GSK-Genmab blood cancer drug approved in US

November 2, 2009 Research and Development, Sales and Marketing Arzerra

GlaxoSmithKline and Philadelphia-based Genmab have received accelerated US approval for their blood cancer drug Arzerra. It is to be used …
News

AstraZeneca withdraws filings for lung cancer drug

November 2, 2009 Research and Development, Sales and Marketing AZ, zactima

AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …
News

GSK begins phase III COPD trials

October 28, 2009 Research and Development, Sales and Marketing COPD, GSK, GlaxoSmithKline, Seretide, Theravance, resp, respiratory

GlaxoSmithKline and San Francisco biopharma firm Theravance have begun a phase III trial to develop a new treatment for chronic …
News
Tarceva tablets

Comparing notes: UK’s cancer leaders discuss the latest advances

October 28, 2009 Research and Development, Sales and Marketing Cancer

 
Feature
Ipsen Claude

Claude Bertrand joins Ipsen as Chief Scientific Officer

October 27, 2009 Research and Development appointment, ipsen, research and development

Ipsen has appointed Claude Bertrand (pictured) chief scientific officer and Jacques-Pierre Moreau chief scientific advisor.Bertrand moves to the company next …
Appointment

Quintiles will open new clinical unit in London next year

October 27, 2009 Research and Development NHS, Quintiles

Quintiles has agreed to set up a clinical research unit in London that will allow it to tap into the …
News

Consolidation wave likely to continue among European CROs

October 27, 2009 Research and Development cros

Another report concluding that the most successful contract research organisations (CROs) will be those that can offer a broad range …
News

Contract research news in brief

October 26, 2009 Research and Development cros

Pharmafocus' round-up of contract research news includes ICON's Q3 results, expansion plans at ClinTec and a prestigious award for Bilcare
News

Critical Pharma gets Wellcome funding for biologic spray technology

October 26, 2009 Research and Development critical pharma

A nasal spray technology which promises an alternative drug delivery method for biologic drugs has been given a funding boost. …
News

Andrew Sandham, executive chairman, Syntaxin

October 20, 2009 Research and Development appointment, appointments, research and development, syntaxin

Syntaxin, a biopharmaceutical company developing novel biologic drugs that control cell secretion, has appointed Andrew Sandham executive chairman.This follows the …
Appointment
Cellectis Sylvie

Cellectis appoints Dr Sylvie Delassus Senior Vice President Communications

October 20, 2009 Research and Development appointment, cellectis, research and development

French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive …
Appointment
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026